Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno DrugsDHA:TECHNODRUG -2.27%37 Days Payable is 37.27 as of Mar. 2026, which is 201% above its 10-year median of 12.40. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 10 warning signs investors should review. Among 925 Drug Manufacturers companies, Techno Drugs ranks worse than 92.11% on this metric.
The historical rank and industry rank for Techno Drugs's Days Payable or its related term are showing as below:
DHA:TECHNODRUG'
s Days Payable Range Over the Past 10 Years
Min: 11.37 Med: 12.4 Max: 26.36
Current: 26.36
During the past 2 years, Techno Drugs's highest Days Payable was 26.36. The lowest was 11.37. And the median was 12.40.
DHA:TECHNODRUG's Days Payable is ranked worse than 92.11% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs DHA:TECHNODRUG: 26.36
Techno Drugs's Days Payable
declined
from Mar. 2025 (39.32) to Mar. 2026 (37.27).
It may suggest that Techno Drugsaccelerated paying its suppliers.
Techno Drugs Days Payable Related Terms
Techno Drugs Days Payable Historical Data
* Premium members only.
The historical data trend for Techno Drugs's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:TECHNODRUG vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Techno Drugs's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Drugs Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Techno Drugs's Days Payable distribution charts can be found below:
* The bar in red indicates where Techno Drugs's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Techno Drugs's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Drugs (DHA:TECHNODRUG) has a Days Payable of 37.27 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Techno Drugs and its competitors. This is 201% above median its historical median of 12.40. Over the past decade, Techno Drugs' Days Payable has ranged from 11.37 to 26.36. According to the industry distribution chart, Techno Drugs ranks #852 out of 925 companies in the Drug Manufacturers industry, placing it in the top 92.1%.
Is Techno Drugs' Days Payable too high?
Techno Drugs' current Days Payable of 37.27 is 201% above median its 10-year median of 12.40. Over the past 10 years, this metric has ranged from a low of 11.37 to a high of 26.36. The Drug Manufacturers industry median Days Payable is 90.38. Techno Drugs' value of 37.27 is 58.8% below this industry median. Based on the distribution chart, Techno Drugs ranks #852 out of 925 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Techno Drugs ranks #852 out of 925 companies for Days Payable. This places Techno Drugs in the lower half of its industry. The industry median Days Payable is 90.38. Techno Drugs' value of 37.27 is 58.8% below this benchmark. Historically, Techno Drugs' own Days Payable has ranged from 11.37 to 26.36 over the past decade. While the company's 10-year median is 12.40 vs. the industry median of 90.38, Techno Drugs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Drugs's current Days Payable of 37.27 is 58.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Techno Drugs and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Drugs's current Days Payable is 37.27, which is 201% above median its own 10-year median of 12.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current Days Payable of 37.27. The current Days Payable is 37.27, which is 201% above median its 10-year median of 12.40 and 58.8% below the Drug Manufacturers industry median of 90.38. Techno Drugs' overall GF Score™ is 37/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current Days Payable is 37.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score
Get the complete analysis for DHA:TECHNODRUG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:TECHNODRUG has been successfully added to your 
